Papers on
BDKRB1
The landscape of copy number variations in Finnish families with autism spectrum disorders.Järvelä et al., Helsinki, Finland. In Autism Res, Jul 2015
Additionally, several novel candidate genes (BDKRB1, BDKRB2, AP2M1, SPTA1, PTH1R, CYP2E1, PLCD3, F2RL1, UQCRC2, LILRB3, RPS9, and COL11A2) were identified through gene prioritization.
Pharmacogenetics of new analgesics.Geisslinger et al., Frankfurt am Main, Germany. In Br J Pharmacol, 2011
Among G protein coupled receptors, δ-opioid receptors (coded by OPRD1), cannabinoid receptors (CNR1 and CNR2), metabotropic glutamate receptors (mGluR5 coded by GRM5), bradykinin B(1) (BDKRB1) and 5-HT(1A) (HTR1A) receptors are targeted by new analgesic substances.
Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.Torra et al., Barcelona, Spain. In Nephrol Dial Transplant, 2007
The candidate genes (and polymorphisms) studied were the following: NOS3 (T-786C and E298D), BDKRB1 (-699 G > C), BDKRB2 (R14C), TGFB1 (-509 C > T, R25P and L10P), ACE (I/D), EGFR (IVS1CA) and PKD2 (-9780 G > A, -718 A > G and 83 C > G).